These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 23579391)

  • 1. Stemming the global trade in falsified and substandard medicines.
    Gostin LO; Buckley GJ; Kelley PW
    JAMA; 2013 Apr; 309(16):1693-4. PubMed ID: 23579391
    [No Abstract]   [Full Text] [Related]  

  • 2. Combatting substandard and falsified medicines: a view from Rwanda.
    Binagwaho A; Bate R; Gasana M; Karema C; Mucyo Y; Mwesigye JP; Biziyaremye F; Nutt CT; Wagner CM; Jensen P; Attaran A
    PLoS Med; 2013; 10(7):e1001476. PubMed ID: 23843747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The primacy of public health considerations in defining poor quality medicines.
    Newton PN; Amin AA; Bird C; Passmore P; Dukes G; Tomson G; Simons B; Bate R; Guerin PJ; White NJ
    PLoS Med; 2011 Dec; 8(12):e1001139. PubMed ID: 22162953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Forensic pharmacovigilance and substandard or counterfeit drugs.
    Labadie J
    Int J Risk Saf Med; 2012; 24(1):37-9. PubMed ID: 22436258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Legal aspects of counteracting the trafficking of falsified medicines in the european union.
    Pashkov V; Soloviov A; Olefir A
    Wiad Lek; 2017; 70(4):843-849. PubMed ID: 29064815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Counterfeit and Falsified Drugs: an Overview].
    Taverriti-Fortier C; Pape E; Scala-Bertola J; Tréchot P; Maincent P; Gibaja V; Gambier N
    Therapie; 2015; 70(5):455-64. PubMed ID: 26071144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Public health interventions to protect against falsified medicines: a systematic review of international, national and local policies.
    Hamilton WL; Doyle C; Halliwell-Ewen M; Lambert G
    Health Policy Plan; 2016 Dec; 31(10):1448-1466. PubMed ID: 27311827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Curbing the circulation of counterfeit medicines in Nigeria.
    Fatokun O
    Lancet; 2016 Nov; 388(10060):2603. PubMed ID: 27832872
    [No Abstract]   [Full Text] [Related]  

  • 9. Surveillance for falsified and substandard medicines in Africa and Asia by local organizations using the low-cost GPHF Minilab.
    Petersen A; Held N; Heide L;
    PLoS One; 2017; 12(9):e0184165. PubMed ID: 28877208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Fake drugs, what are we talking about? Counterfeit drugs, informal market, quality of pharmaceutical… Thought from an anthropological study led in Benin].
    Baxerres C
    Bull Soc Pathol Exot; 2014 May; 107(2):121-6. PubMed ID: 24639135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of Substandard and Falsified Medicines: Influence of Different Tolerance Limits and Use of Authenticity Inquiries.
    Hauk C; Hagen N; Heide L
    Am J Trop Med Hyg; 2021 Mar; 104(5):1936-1945. PubMed ID: 33788775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trade systems in less-developed countries.
    Kamal Smith M; 't Hoen E
    Lancet; 2001 May; 357(9268):1624. PubMed ID: 11386324
    [No Abstract]   [Full Text] [Related]  

  • 13. Trade systems in less-developed countries.
    Nicholson J
    Lancet; 2001 May; 357(9268):1624. PubMed ID: 11386325
    [No Abstract]   [Full Text] [Related]  

  • 14. Counterfeit and substandard malaria drugs in Africa.
    Brower V
    Lancet Infect Dis; 2017 Oct; 17(10):1026-1027. PubMed ID: 28948928
    [No Abstract]   [Full Text] [Related]  

  • 15. Substandard and Falsified Medicines: Proposed Methods for Case Finding and Sentinel Surveillance.
    Pisani E; Hasnida A; Rahmi M; Kok MO; Harsono S; Anggriani Y
    JMIR Public Health Surveill; 2021 Aug; 7(8):e29309. PubMed ID: 34181563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ensuring global access to quality medicines: role of the US Pharmacopeia.
    ; ; ; Heyman ML; Williams RL
    J Pharm Sci; 2011 Apr; 100(4):1280-7. PubMed ID: 24081465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Medicines Quality Database: a free public resource.
    Krech LA; El-Hadri L; Evans L; Fouche T; Hajjou M; Lukulay P; Phanouvong S; Pribluda V; Roth L
    Bull World Health Organ; 2014 Jan; 92(1):2-2A. PubMed ID: 24391291
    [No Abstract]   [Full Text] [Related]  

  • 18. When falsified medicines enter the supply chain: description of an incident in Kenya and lessons learned for rapid response.
    Cohn J; von Schoen-Angerer T; Jambert E; Arreghini G; Childs M
    J Public Health Policy; 2013 Jan; 34(1):22-30. PubMed ID: 23172047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Missourians face risk in counterfeit medicines.
    Lawler T
    Mo Med; 2009; 106(3):177-82. PubMed ID: 22641912
    [No Abstract]   [Full Text] [Related]  

  • 20. A cross-sectional analysis of falsified, counterfeit and substandard medicines in a low-middle income country.
    Khurelbat D; Dorj G; Sunderland B; Sanjjav T; Bayarsaikhan E; Damdinjav D; Dorj G; Jigjidsuren A; Lkhagvasuren O; Erdenetsetseg B
    BMC Public Health; 2020 May; 20(1):743. PubMed ID: 32434489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.